Howard Greenman

Howard Greenman has extensive work experience in business development, strategy, and executive leadership roles. Howard is currently the Vice President of Business Development at Akili Interactive since 2021. Prior to that, they worked as the Senior Director of New Ventures at Sema4 from 2019 to 2021. From 2009 to 2019, they served as the Chief Executive Officer of Provia Laboratories: Store-A-Tooth, where they successfully developed the business, managed fundraising efforts, and acquired competing companies.

Before their role at Provia Laboratories, Howard worked at Healthcare IT, formerly Gulfstream Bio, from 2006 to 2009, where they held the title of VP of Product Strategy and Business Development and also served as Interim CEO. Howard also worked at Philips Medical Systems as a Senior Manager of Strategy and Business Development from 2005 to 2006.

Howard's earlier experience includes working at Ardais Corporation, where they held various positions such as Director of Strategy and Business Development, Director of Product Management, and was a part of the executive team responsible for launching a new line of business. Howard also founded and served as the Director of Product and Operations at MedXtend.

Howard's career began with roles at The Boston Consulting Group as a Summer Associate, Oracle as a Senior Data Warehouse Consultant, and Accenture as a Senior Consultant in Healthcare Technology. Overall, they have a strong background in business development, strategic planning, and executive leadership, with a focus on healthcare and life sciences industries.

Howard Greenman earned a Master of Business Administration (MBA) in Healthcare Management from The Wharton School in 1998-2000. Prior to that, they completed their undergraduate studies at Babson College, where they obtained a Bachelor of Science (BS) in Business Administration and Entrepreneurship from 1990-1994. Howard Greenman also attended Miami Palmetto Senior High School, although specific dates and degrees obtained are not provided.